Liver Center Member Publications

Member publications appearing in PubMed September 2017 *

* Liver-related publications only

Dew MA, Butt Z, Liu Q, Simpson MA, Zee J, Ladner DP, Holtzman S, Smith AR, Pomfret EA, Merion RM, Gillespie BW, Sherker AH, Fisher RA, Olthoff KM, Burton JR Jr, Terrault NA, Fox AN, DiMartini AF. Prevalence and Predictors of Patient-Reported Long-Term Mental and Physical Health After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL). Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001942. [Epub ahead of print] PubMed

Fleming JN, Lai JC, Te HS, Said A, Spengler E, Rogal SS. Opioid and Opioid Substitution Therapy in Liver Transplant Candidates: A Survey of Center Policies and Practices. Clin Transplant. 2017 Sep 23. doi: 10.1111/ctr.13119. [Epub ahead of print] PubMed

Jia J, Qiao Y, Pilo MG, Cigliano A, Liu X, Shao Z, Calvisi DF, Chen X. Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade. PLoS One. 2017 Sep 6;12(9):e0184068. doi: 10.1371/journal.pone.0184068. eCollection 2017. PubMed

Keating SM, Dodge JL, Norris PJ, Heitman J, Gange SJ, French AL, Glesby MJ, Edlin BR, Latham PS, Villacres MC, Greenblatt RM, Peters MG; Women’s Interagency HIV Study. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study. PLoS One. 2017 Sep 13;12(9):e0181004. doi: 10.1371/journal.pone.0181004. eCollection 2017. PubMed

Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. Misdiagnosis of Hepatocellular Carcinoma in Patients Receiving no Loco-regional Therapy Prior to Liver Transplant: An Analysis of the OPTN Explant Pathology Form. Clin Transplant. 2017 Sep 7. doi: 10.1111/ctr.13107. [Epub ahead of print]  PubMed

Nabekura T, Gotthardt D, Niizuma K, Trsan T, Jenus T, Jonjic S, Lanier LL. Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection. J Immunol. 2017 Sep 1;199(5):1567-1571. doi: 10.4049/jimmunol.1700799. Epub 2017 Jul 31. PubMed

Pierce AA, Duwaerts CC, Siao K, Mattis AN, Goodsell A, Baron JL, Maher JJ. CD18 deficiency improves liver injury in the MCD model of steatohepatitis. PLoS One. 2017 Sep 5;12(9):e0183912. doi: 10.1371/journal.pone.0183912. eCollection 2017. PubMed

Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients. Transplantation. 2017 Sep;101(9):2079-2082. doi: 10.1097/TP.0000000000001786. PubMed

VanWagner LB, Khan SS, Ning H, Siddique J, Lewis CE, Carr JJ, Vos MB, Speliotes E, Terrault NA, Rinella ME, Lloyd-Jones DM, Allen NB. Body Mass Index Trajectories in Young Adulthood Predict Nonalcoholic Fatty Liver Disease in Middle Age: The CARDIA Cohort Study. Liver Int. 2017 Sep 29. doi: 10.1111/liv.13603. [Epub ahead of print]  PubMed

Wang Y, Paulo E, Wu D, Wu Y, Huang W, Chawla A, Wang B. Adipocyte Liver Kinase b1 Suppresses Beige Adipocyte Renaissance Through Class IIa Histone Deacetylase 4. Diabetes. 2017 Sep 7. pii: db170296. doi: 10.2337/db17-0296. [Epub ahead of print] PubMed

Xing Y, Morohashi KI, Ingraham HA, Hammer GD. Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. Development. 2017 Sep 11. pii: dev.150516. doi: 10.1242/dev.150516. [Epub ahead of print] PubMed

Younossi ZM, Stepanova M, Balistreri W, Schwarz K, Murray KF, Rosenthal P, Bansal S, Hunt S. Health-Related Quality of Life in Adolescent Patients with Hepatitis C Genotype 1 Treated with Sofosbuvir and Ledipasvir. J Pediatr Gastroenterol Nutr. 2017 Sep 27. doi: 10.1097/MPG.0000000000001754. [Epub ahead of print] PubMed

Zhang M, Lei D, Peng B, Yang M, Zhang L, Art Charles M, Rye KA, Krauss RM, Johns DG, Ren G. Assessing the mechanisms of cholesteryl ester transfer protein inhibitors. Biochim Biophys Acta. 2017 Sep 11. pii: S1388-1981(17)30189-0. doi: 10.1016/j.bbalip.2017.09.004. [Epub ahead of print] PubMed